Wesfarmers (ASX:WES) share price falls after API rejects takeover offer

Wesfarmers has hit a major stumbling block in its attempt to take over the Priceline owner…

| More on:
A woman crosses her hands in front of her body in a defensive stance indicating a trading halt.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Wesfarmers Ltd (ASX: WES) share price is trading lower on Thursday morning.

At the time of writing, the conglomerate's shares are down 1% to $61.01.

Why is the Wesfarmers share price trading lower?

The weakness in the Wesfarmers share price on Thursday has been driven by news that its takeover offer for Australian Pharmaceutical Industries Ltd (ASX: API) has been rejected.

On 12 July Wesfarmers tabled a $1.38 cash per share offer to acquire the pharmacy chain operator and distributor by way of a scheme of arrangement.

This morning Australian Pharmaceutical Industries announced that its board has carefully considered the proposal, including obtaining advice from its financial and legal advisers.

However, the Board has unanimously concluded that the proposal undervalues the company, is not compelling, and is not in the best interests of shareholders.

Why did it reject the offer?

The Australian Pharmaceutical Industries Board advised that it has undertaken a detailed analysis of the underlying value of the company. This includes assessing its medium and long term growth prospects and reviewing a range of scenarios in relation to its recovery from the impacts of COVID-19 and the related lockdown restrictions.

Following this, it believes Wesfarmers' offer is opportunistic given the impact COVID-19 and lockdown restrictions have had on its financial performance over the last 18 months, and particularly on its retail facing businesses.

It also feels that its portfolio of complementary wholesale and retail businesses are strategically well positioned in the growing health, wellness, and beauty sector.

In addition, Australian Pharmaceutical Industries notes the potential of its investment in 39 new Clear Skincare clinics over the past three years since the business was acquired and the continued expansion of its clinic network.

Another factor it feels is being overlooked is the expected savings from completing the development of the new automated Marsden Park Distribution Centre by the end of FY 2022. This will allow the consolidation of its supply chain footprint.

Finally, the Board notes that the premium offered by Wesfarmers was significantly below the Australian market average for transactions of this nature.

It concluded: "Although API's share price has recently traded above the price offered in the Indicative Proposal, the Board recognises that the share price may trade below this level in the short term. Nevertheless, the Board will only progress a change of control transaction on terms that recognise the fundamental value of API and are in the best interests of API shareholders as a whole."

The Wesfarmers share price is up 19% in 2021.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Mergers & Acquisitions

A man stands with his arms crossed in an X shape.
Mergers & Acquisitions

Boral share price falls after rejecting Seven Group takeover

The offer 'undervalues' Boral according to its committee.

Read more »

Miner looking at a tablet.
Materials Shares

Mineral Resources share price marching higher on new lithium project acquisition

ASX 200 investors are bidding up the Mineral Resources share price on Monday.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Technology Shares

Appen shares plunges 17% after takeover collapse

Well that didn't take long...

Read more »

a woman wearing a dark business suit holds her hand up in a stop gesture while sitting at a desk. She has a sombre look on her face.
Financial Shares

Guess which ASX All Ords stock is suspended amid takeover rumours

Another ASX share is rumoured to have received a takeover offer.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Technology Shares

Why are Appen shares crashing 21% today?

This beaten down tech stock has received a takeover offer. But did the market expect too much?

Read more »

A man pulls a shocked expression with mouth wide open as he holds up his laptop.
Technology Shares

Appen share price on watch following takeover offer

But will the offer price be a huge disappointment to investors?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Technology Shares

What caused this small-cap ASX stock to surge 90% today?

Investors are celebrating some big news on Monday.

Read more »

Three businesspeople leap high with the CBD in the background.
Bank Shares

Virgin Money share price pops 34% on takeover bid

This UK bank could be leaving the ASX boards in the near future.

Read more »